Susan G. Komen Missouri Metastatic Breast Cancer Conference

Komen Missouri has been working with members of the metastatic breast cancer community in the St. Louis metro area to identify opportunities for support, engagement and education. Guided by our planning committee, this event recognizes the distinct experience of metastatic breast cancer patients and is tailored to fit their needs and interests. Specifically, conference attendees will have the opportunity to discuss treatment breakthroughs, ongoing clinical trials, quality of life issues and patient advocacy.

Date: Saturday, February 22, 2020
Time: 7:30 a.m. – 5 p.m.
Location: Il Monastero, 3050 Olive Street, St. Louis, MO 63103

Audience: This conference is designed for individuals living with metastatic breast cancer, their caregivers and their providers. In addition, it seeks to bring together diverse perspectives that influence the lives of metastatic patients, including breast cancer survivors, researchers, providers, insurers and policymakers.

This event is free to members of the intended audience. Space is limited to 150 guests. To register, click here.

The conference has been made possible in part thanks to the support of our partners:

SUSIE KNOPF

Conference Agenda:

7:30 – 8:30 a.m. Check-in/Continental Breakfast

8:30 – 8:35 a.m. Welcome and Opening Remarks
Suzanne Fontaine, Executive Director, Susan G. Komen Missouri

8:35 – 9:15 a.m. Keynote Address: Working Together to Change the Odds
Josh Newby, Founder & CEO, Theresa’s Research Foundation

9:30 – 10:15 a.m. Key Takeaways from the San Antonio Breast Cancer Symposium
Dr.  Cynthia Ma, breast cancer researcher, Washington University School of Medicine
Dr. Ashley Frith, breast oncologist, Siteman Cancer Center

10:30 – 11:15 a.m. Breakout Sessions A & B
* Clinical Trials 101 – Lianne Kraemer, patient research advocate; Jill Anderson and Tracy Summa, clinical research coordinators, Washington University School of Medicine
* The MBC Project – Michael Dunphy, Senior Manager, The Broad Institute of MIT and Harvard

11:30 a.m. – 12:15 p.m. Lunch & Learn – MBC Survivors Panel

12:30 – 1:15 p.m. Repeat Breakout Sessions A & B
(attendees go to session they didn’t attend the first time)

1:30 – 2:15 p.m. Session on Specific Type of Cancer Metastasis
Participants choose one of the following topics:
* Triple-Negative – Dr. Salman Hyder, University of Missouri – Columbia
* HER2+ – Dr. Ron Bose, Washington University/Siteman Cancer Center
* Bone Metastasis – Dr. Nusayba Bagegni, Washington University/Siteman Cancer Center

2:30 – 3:15 p.m. Session on Self-Care/Coping
Participants choose one of the following topics:
* Fighting Financial Toxicity Molly MacDonald, Founder/CEO, The Pink Fund
* Complementary and Integrative Therapies Dr. Michelle Smith, Mercy Integrative Health

3:30 – 4 p.m. Closing Session: Empowerment Through Advocacy
Sheila McGlown, patient advocate
Suzanne Fontaine, Executive Director, Susan G. Komen Missouri

4:05 – 5 p.m. Networking and Fellowship Reception